TrueMed’s Digital Forensic Lab Selected by Additional Top 10 Global Pharma to Advance Anti-Counterfeiting

February 06, 2024 09:24 PM AEDT | By EIN Presswire
 TrueMed’s Digital Forensic Lab Selected by Additional Top 10 Global Pharma to Advance Anti-Counterfeiting
Image source: EIN Presswire
FINLAND, February 6, 2024 /EINPresswire.com/ -- TrueMed, the leading provider of anti-counterfeiting technology solutions for pharmaceuticals, announces a strategic collaboration with an additional global leader in pharmaceuticals and healthcare. An additional top 10 pharmaceutical company has joined forces with TrueMed, reflecting a shared commitment to combat the surge of counterfeit and illicit medicines. Leveraging TrueMed's Digital Forensic Lab and advanced AI technology, the collaboration is poised to make a meaningful impact on patient safety by effectively detecting and addressing counterfeit drugs.

TrueMed's innovative AI platform, utilizing mobile phone cameras, artificial intelligence to reach high accuracy, and data analytics, is at the forefront of accurately identifying counterfeit pharmaceuticals, strengthening the pharmaceutical company's capacity for investigation and response. This technology is integral to forensic analyses and seamlessly integrates with existing security processes, streamlining the fight against fake medications without necessitating costly manufacturing changes.

TrueMed was chosen as a partner for its expertise and commitment to the safety and integrity of medicines. This collaboration is centered on enhancing laboratory capabilities to efficiently identify and investigate counterfeit drugs. The partnership aims to guarantee the delivery of safe and authentic treatments, addressing a crucial need in healthcare for dependable and effective medication.

Jyrki Berg, CEO of TrueMed, remarked on the significance of this collaboration, noting, "Our strategic alliance with this pharmaceutical leader is a significant step towards directly addressing the challenge of counterfeit drugs. Through this partnership, we're employing the latest technologies and drawing on deep industry expertise to significantly advance patient safety globally."

This partnership reflects a shared goal in the pharmaceutical industry to innovate and improve patient care. It shows how AI is important in keeping healthcare safe and marks a significant step forward in working together to protect health worldwide.
For additional insights into TrueMed's advanced AI-based anti-counterfeiting solutions, please visit www.truemedinc.com.

About TrueMed.

TrueMed is a leading provider of anti-counterfeiting technology solutions. The company's AI-enabled platform uses cutting-edge technology to analyze and identify potential counterfeit products, allowing companies to quickly and efficiently protect their brands and their customers.

For more information, please visit truemedinc.com.
Contact: Tuomas Kannas, TrueMed, [email protected]

Tuomas Kannas
TrueMed Oy
+358 50 5680782
email us here


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Pty Ltd (“Kalkine Media, we or us”), ACN 629 651 672 and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content.
Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyrighted to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have made reasonable efforts to accredit the source wherever it was indicated as or found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


AU_advertise

Advertise your brand on Kalkine Media

Sponsored Articles


Investing Ideas

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.